Defining risk groups to yellow fever vaccine-associated viscerotropic disease in the absence of denominator data

American Journal of Tropical Medicine and Hygiene

Volumn 90, Issue 2, 2014, Pages 267-271

  Seligman, Stephen J ^a   Cohen, Joel E ^b,c   Itan, Yuval ^b   Casanova, Jean Laurent ^b   Pezzullo, John C ^d  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERNICIOUS ANEMIA; PREVALENCE; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMECTOMY; THYMOMA; VACCINATION REACTION; VISCEROTROPIC DISEASE; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS; YELLOW FEVER VACCINE ASSOCIATED VISCEROTROPIC DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; CONFIDENCE INTERVALS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; VACCINATION; VACCINES, ATTENUATED; YELLOW FEVER; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS; YOUNG ADULT;

EID: 84893441165     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0542     Document Type: Article

References (14)

1. Monath TP, Gershman M, Staples JE, Barrett AD, 2012. Yellow fever vaccine. Plotkin SA, Orenstein WA, and Offit PA, eds. Vaccines. Sixth edition. China: Saunders, 870-968.
2. Monath TP, 2012. Review of the risks and benefits of yellow fever vaccination including some new analyses. Expert Rev Vaccines 11: 427-448.
3. Barwick R, 2004. History of thymoma and yellow fever vaccination. Lancet 364: 936. (Pubitemid 39208454)
4. Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 6077-6082.
5. Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, Cetron MS, 2005. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 23: 3256-3263. (Pubitemid 40523118)
6. Seligman SJ, 2011. Yellow fever virus vaccine-associated deaths in young women. Emerg Infect Dis 17: 1891-1893.
7. Gershman MD, Staples JE, Bentsi-Enchill AD, Breugelmans JG, Brito GS, Bastos Camacho LA, Cottin P, Domingo C, Durbin A, Gascon J, Guenaneche F, Hayes EB, Jelenik Z, Khromava A, Martins RD, Wilson MM, Massy N, Nasidi A, Niedrig M, Sherwat A, Tsai T, Vilella A, Wilson ME, Kohl KS, 2012. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 30: 5038 -5058.
8. Isenman H, Burns A, 2012. A case of yellow fever vaccine-associated disease. NZ Med J 125: 92-95.
9. Breugelmans JG, Lewis RF, Agbenu E, Veit O, Jackson D, Domingo C, Bothe M, Perea W, Niedrig M, Gessner BD, Yactayo S, 2013. Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010. Vaccine 31: 1819-1829.
10. Altman DG, Bland JM, 2011. How to obtain the P value from a confidence interval. BMJ 343: d2304.
11. Casanova JL, Abel L, 2009. Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med 206: 1839-1843.
12. Pulendran B, Miller J, Querec TD, Akondy R, Moseley N, Laur O, Glidewell J, Monson N, Zhu T, Zhu H, Staprans S, Lee D, Brinton MA, Perelygin AA, Vellozzi C, Brachman P Jr, Lalor S, Teuwen D, Eidex RB, Cetron M, Priddy F, del Rio C, Altman J, Ahmed R, 2008. Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis 198: 500-507.
13. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A, 1995. Immunological conditions of children with BCG disseminated infection. Lancet 346: 581.
14. Alcais A, Quintana-Murci L, Thaler DS, Schurr E, Abel L, Casanova JL, 2010. Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann N Y Acad Sci 1214: 18 -33.